Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MNV-BM-BLD for Pearson Syndrome
NCT03384420Phase 2Completed
- Sponsor
- Minovia Therapeutics
- Start
- Feb 2019
- Primary completion
- Mar 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of MNV-101 in Pearson syndrome, sponsored by Minovia Therapeutics. Started Feb 2019; status: completed.
02
Drugs
MNV-101
03
Conditions
Pearson syndrome
Beyond the preview
Go deeper on NCT03384420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03384420.